Completed PHASE4 INTERVENTIONAL 3-arm NCT02959229

Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis

Systematic Randomized , Single Blinded, Placebo-Controlled Trial of Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis

Sponsor: Ain Shams University

Conditions Neonatal Sepsis

Interventions Lactoferrin Placebo (for Lactoferrin)

Updated 6 times since 2017 Last updated: Nov 5, 2016 Started: Aug 31, 2014 Primary completion: Dec 31, 2015 Completion: Oct 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02959229, this PHASE4 trial focuses on Neonatal Sepsis and remains completed. Sponsored by Ain Shams University, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Aug 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.